These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9598116)

  • 1. Azathioprine treatment and thiopurine metabolism in rheumatic diseases. Introduction and first results of investigation.
    Stolk JN; Boerbooms AM; De Abreu RA; van de Putte LB
    Adv Exp Med Biol; 1998; 431():487-93. PubMed ID: 9598116
    [No Abstract]   [Full Text] [Related]  

  • 2. Purine enzymes in rheumatoid arthritis: possible association with response to azathioprine. A pilot study.
    Kerstens PJ; Stolk JN; Boerbooms AM; Lambooy LH; de Graaf R; De Abreu RA; van de Putte LB
    Ann Rheum Dis; 1994 Sep; 53(9):608-11. PubMed ID: 7979599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine.
    Marra CA; Esdaile JM; Anis AH
    J Rheumatol; 2002 Dec; 29(12):2507-12. PubMed ID: 12465143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current problems of immunology and immunosuppressive therapy in rheumatic diseases].
    Vorlaender KO
    Clin Ter; 1967 Jul; 42(1):3-14. PubMed ID: 4386113
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of plasma azathioprine and 6-mercaptopurine in patients with rheumatoid arthritis treated with oral azathioprine.
    Liliemark J; Pettersson B; Lafolie P; Zweig T; Peterson C
    Ther Drug Monit; 1990 Jul; 12(4):339-43. PubMed ID: 2396307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine.
    Clunie GP; Lennard L
    Rheumatology (Oxford); 2004 Jan; 43(1):13-8. PubMed ID: 14566029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolite monitoring to guide thiopurine therapy in systemic autoimmune diseases.
    Chapdelaine A; Mansour AM; Troyanov Y; Williamson DR; Doré M
    Clin Rheumatol; 2017 Jun; 36(6):1341-1348. PubMed ID: 28130685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphocyte transformation during immunosuppressive therapy of lupus erythematosus visceralis].
    Heine KM; Klatt R; Stobbe H; Apostoloff E; Jendrusch C
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:152-4. PubMed ID: 5402572
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenetics for the individualization of treatment of rheumatic disorders using azathioprine.
    Seidman EG; Furst DE
    J Rheumatol; 2002 Dec; 29(12):2484-7. PubMed ID: 12465139
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of azathioprine on gammaglobulin synthesis in man.
    Levy J; Barnett EV; MacDonald NS; Klinenberg JR; Pearson CM
    J Clin Invest; 1972 Sep; 51(9):2233-8. PubMed ID: 4629438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK and NKT cell dynamics after rituximab therapy for systemic lupus erythematosus and rheumatoid arthritis.
    Reis EA; Athanazio DA; Lima I; Oliveira e Silva N; Andrade JC; Jesus RN; Barbosa LM; Reis MG; Santiago MB
    Rheumatol Int; 2009 Feb; 29(4):469-75. PubMed ID: 18821073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should we test TPMT enzyme levels before starting azathioprine?
    Richard VS; Al-Ismail D; Salamat A
    Hematology; 2007 Aug; 12(4):359-60. PubMed ID: 17654066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [T-helper cell subsets in patients with inflammatory rheumatic diseases undergoing immunosuppressive therapy].
    Becker H; Potyka P; Weber C; Renelt M; Federlin K
    Immun Infekt; 1991 Feb; 19(1):26-7. PubMed ID: 1829436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The European League Against Rheumatism (EULAR) - 16th Annual European Congress (June 10-13, 2015 - Rome, Italy).
    Ollé M
    Drugs Today (Barc); 2015 Jun; 51(6):387-92. PubMed ID: 26261853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases.
    Hu C; Lu L; Wan JP; Wen C
    Curr Med Chem; 2017; 24(20):2241-2249. PubMed ID: 28302011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavior of the rheumatoid factor under long-term penicillamine therapy in primary chronic polyarthritis and lupus erythematosus disseminatus].
    Prohaska E
    Wien Z Inn Med; 1966 May; 47(5):196-202. PubMed ID: 6005164
    [No Abstract]   [Full Text] [Related]  

  • 18. [Research on the effects of azathioprine (Imuran) in rheumatoid arthritis and lupic diseases].
    Bruckner I; Stroescu O; Stroescu V; Gheorghiu M; Suţeanu S; Ghelerter L; Grozea P; Bârnaş M
    Med Interna (Bucur); 1969 May; 21(5):583-92. PubMed ID: 5344550
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
    Fox DA; McCune WJ
    Concepts Immunopathol; 1989; 7():20-78. PubMed ID: 2676180
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of immunosuppressive drugs in rheumatic diseases.
    Steinberg AD
    Arthritis Rheum; 1973; 16(1):92-6. PubMed ID: 4540291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.